Nuveen Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $881K | Hold |
112,483
| – | – | ﹤0.01% | 2764 |
|
|
2024
Q3 | $1.48M | Hold |
112,483
| – | – | ﹤0.01% | 2575 |
|
|
2024
Q2 | $1.36M | Sell |
112,483
-155,247
| -58% | -$1.88M | ﹤0.01% | 2570 |
|
|
2024
Q1 | $4.35M | Sell |
267,730
-132,210
| -33% | -$2.15M | ﹤0.01% | 2057 |
|
|
2023
Q4 | $2.73M | Buy |
399,940
+41,541
| +12% | +$283K | ﹤0.01% | 2270 |
|
|
2023
Q3 | $1.95M | Sell |
358,399
-66,432
| -16% | -$362K | ﹤0.01% | 2300 |
|
|
2023
Q2 | $2.88M | Buy |
424,831
+91,439
| +27% | +$621K | ﹤0.01% | 2173 |
|
|
2023
Q1 | $1.67M | Buy |
333,392
+229,329
| +220% | +$1.15M | ﹤0.01% | 2413 |
|
|
2022
Q4 | $508K | Buy |
104,063
+99
| +0.1% | +$483 | ﹤0.01% | 2879 |
|
|
2022
Q3 | $1.5M | Sell |
103,964
-4,062
| -4% | -$58.6K | ﹤0.01% | 2549 |
|
|
2022
Q2 | $1.63M | Buy |
108,026
+1,256
| +1% | +$19K | ﹤0.01% | 2541 |
|
|
2022
Q1 | $1.26M | Buy |
106,770
+1,261
| +1% | +$14.9K | ﹤0.01% | 2717 |
|
|
2021
Q4 | $1.62M | Sell |
105,509
-34,704
| -25% | -$534K | ﹤0.01% | 2665 |
|
|
2021
Q3 | $4M | Sell |
140,213
-21,412
| -13% | -$611K | ﹤0.01% | 2334 |
|
|
2021
Q2 | $5.46M | Buy |
161,625
+33,288
| +26% | +$1.13M | ﹤0.01% | 2195 |
|
|
2021
Q1 | $3.88M | Buy |
128,337
+1,967
| +2% | +$59.5K | ﹤0.01% | 2292 |
|
|
2020
Q4 | $6.26M | Buy |
126,370
+7,101
| +6% | +$352K | ﹤0.01% | 1953 |
|
|
2020
Q3 | $4.58M | Sell |
119,269
-32,461
| -21% | -$1.25M | ﹤0.01% | 1963 |
|
|
2020
Q2 | $6.56M | Buy |
151,730
+43,950
| +41% | +$1.9M | ﹤0.01% | 1748 |
|
|
2020
Q1 | $2.81M | Buy |
107,780
+2,271
| +2% | +$59.3K | ﹤0.01% | 2025 |
|
|
2019
Q4 | $3.3M | Buy |
105,509
+21,254
| +25% | +$664K | ﹤0.01% | 2209 |
|
|
2019
Q3 | $2.2M | Buy |
84,255
+4,357
| +5% | +$114K | ﹤0.01% | 2355 |
|
|
2019
Q2 | $1.83M | Buy |
+79,898
| New | +$1.83M | ﹤0.01% | 2476 |
|